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Non-compliance and clinical inertia are the main causes of poorly-controlled blood pressure in 
hypertensive patients. Non-compliance fundamentally depends on the patient’s decision not 
to adhere to the prescribed medication regularly. Therapeutic inertia occurs when the 
physicians do not intensify or modify therapy despite knowing that their patients are poorly 
controlled. Forgetfulness is the main cause for lack of adherence and the main reason 
physicians adopt a conservative attitude is because of the acceptance of borderline figures as 
adequate thus not intensifying the therapeutic treatment. 1,2 
The Spanish working group on compliance and clinical inertia, dependent on Spanish 
Society of Hypertension (SEH.LELHA), has been researching these issues in clinical practice 
for over 20 years.3 Their findings concluded good controlled hypertension targets do not 
exceed 50% in Spain, lack of adherence is around 50% and lifestyle modifications 
compliance is between 80 and 95%. They also observed the percentages of clinical inertia 
vary between 30 and 85%, depending on the study design. 
Guidelines emphasize that early control based on overcoming clinical inertia and patient 
non-compliance is necessary in order to achieve the benefits of therapy, especially in 
patients at high cardiovascular risk. Today, many research studies4 are carried out to 
analyze difficulties in clinical practice to overcome both problems. Mainly, they are 
performed with polymedicated patients with multiple diseases as therapeutic complexity 
may influence on medication adherence and physicians accept borderline figures to avoid 
complicating treatment. 
Marquez et al.5 provides relevant information to health professionals about the control of 
hypertensive patients at high vascular risk. Its methodological strengths lie in the study 
design, a prospective longitudinal 6-month follow-up study, and in the sample size, 3600 
patients from 585 primary healthcare centres through out Spain. Their findings show blood 
pressure control was associated with the combination of therapeutic compliance and 
clinical inertia. During the follow-up of this study, blood pressure control increased and 
clinical inertia decreased resulting in unexpected non-compliance increase. Possibly, the 
reason for this was that physicians modified treatment, increased therapeutic complexity 
and as a result, more patients fail to comply with their treatment. Reduction of clinical 
inertia might influence on blood pressure control more than non-compliance, as these 
patients partially comply with treatment. This study also showed clinical inertia was 
associated with the number of diseases suffered and the number of antihypertensive 
agents taken, and non-compliance was related to the number of antihypertensive agents 
taken by patients. As the study progressed, it was expected that the percentage of 
compliant patients decrease in patients taking more than one drug. However, the most 
striking result was the fact that the decrease of compliant patients taking one drug was 
greater, a fact observed by Armario and Waeber 6 recently. 
To achieve recommended blood pressure targets it is necessary to take medication 
correctly and if the compliant patient does not meet the targets, physician should intensify 
treatment. An intervention to consider may be the incorporation of protocols which aim to 
identify incompliant patients and to select the most effective strategies to modify it. These 
protocols should suggest questions which make physicians think about the necessity of 
modifying treatment when patients do not achieve appropriate blood pressure figures. In 
these protocols would have to dismiss other causes that may influence on the lack of 
adherence, e.g. drug interactions, white coat.7,8 
Blackwell 9 stated that much time, effort and money was invested in drugs but nobody ask 
if the patients take medication. Excellent treatments are not useful if the patient does not 
take them and if physicians do not intensify treatment of poorly controlled patients they 
will not achieve the proper targets. The exhaustive study by Marquez et al 5 reveals non-
compliance and clinical inertia are not isolated problems and new strategies, which provide 
solutions for both problems, are needed in clinical practice to achieve hypertensive patient 
good control. 
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